IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bridgebio Pharma Inc

CUSIP: 10806XAB8 | TRACE | 133 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Union Bancaire Privee, UBP SA552,615,000
0.0% of portfolio›$621
Wolverine Asset Management LLC115,868,000
1.2% of portfolio›$180.3M
M&G Plc11,879,000
0.1% of portfolio›$18.4M
AGF Management LTD1,000,000
0.0% of portfolio›$1.5M
Citigroup Inc217,000
0.0% of portfolio›$335.4K
Calamos Advisors LLC162,000
0.0% of portfolio›$252.1K
StyleTurnoverLocationFiled
Union Bancaire Privee, UBP SA
552,615,000$6210.0%GrowthMediumGeneva 1, Switzerland2026-11-04
Wolverine Asset Management LLC
115,868,000$180.3M1.2%Deep ValueVery HighChicago, IL2026-11-02
M&G Plc
11,879,000$18.4M0.1%CoreMediumLondon, United Kingdom2026-11-04
AGF Management LTD
1,000,000$1.5M0.0%GrowthHighToronto, Australia2026-11-03
Citigroup Inc
217,000$335.4K0.0%CoreMediumNew York, NY2026-11-04
Calamos Advisors LLC
162,000$252.1K0.0%GrowthMediumNaperville, IL2026-11-02